Search

everythinglearnresearchcommunity

for

Search:↓

Proxalutamide significantly lowered hospitalization rates in women with mild-to-moderate COVID-19.

The new gel combining calcipotriene and betamethasone is effective and safe for treating scalp psoriasis.

Topical ruxolitinib quickly improves non-segmental vitiligo.

New mouse models of Pemphigus show severe symptoms and need better treatments.

Baricitinib effectively treats alopecia areata, with over half of patients improving after 52 weeks.

A man with severe hair loss saw hair and nail improvement after 10 months on tofacitinib without side effects.

Teriflunomide is an effective and safe first-line oral treatment for relapsing multiple sclerosis.

JAK inhibitors show promise for treating skin conditions like eczema, hair loss, and psoriasis.

Tideglusib may help bone regeneration without being toxic at low doses.

Abrocitinib helped a 14-year-old girl with severe alopecia areata regrow her hair significantly.

Tofacitinib may help regrow hair in alopecia areata patients.

Abrocitinib shows promise for treating various skin conditions beyond atopic dermatitis.

Guilu Erxian Glue may help reduce chemotherapy side effects like weight loss and heart stress.

Tofacitinib and baricitinib had an acceptable level of side effects in rheumatoid arthritis patients.

A woman with a drug allergy to anakinra was successfully desensitized, allowing her to continue treatment without allergic reactions.

Cetuximab can cause skin cysts after acne-like eruptions.

GI197111X is best dissolved in Capmul MCM for trials.

JAK inhibitors help with skin conditions but need more research on dosing and safety.

The composition with carnitine, thioctic acid, and saw palmetto extract may effectively reduce inflammation in hair follicle cells.

Targeted immunological therapies offer safer and more effective treatments for skin conditions like eczema and psoriasis.

Tofacitinib citrate improved nail dystrophy and pain in patients with alopecia universalis without causing side effects.

Dermal IgA deposition without symptoms is rare in Dermatitis herpetiformis risk groups.

Tofacitinib, an arthritis drug, helped hair growth in alopecia universalis but long-term safety needs more research.

A woman's eyelash regrowth was successful using tofacitinib solution for alopecia areata.

Social media can help compare the effectiveness and safety of new arthritis medications.

Baricitinib was effective and safe for severe hair loss treatment over 6 months.

Ruxolitinib cream may help treat severe hair loss in children.